U.S. flag

An official website of the United States government

NM_001323289.2(CDKL5):c.1247_1248del (p.Glu416fs) AND CDKL5 disorder

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Mar 26, 2021
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001507057.5

Allele description [Variation Report for NM_001323289.2(CDKL5):c.1247_1248del (p.Glu416fs)]

NM_001323289.2(CDKL5):c.1247_1248del (p.Glu416fs)

Gene:
CDKL5:cyclin dependent kinase like 5 [Gene - OMIM - HGNC]
Variant type:
Microsatellite
Cytogenetic location:
Xp22.13
Genomic location:
Preferred name:
NM_001323289.2(CDKL5):c.1247_1248del (p.Glu416fs)
Other names:
NM_001323289.2(CDKL5):c.1247_1248del; p.Glu416fs
HGVS:
  • NC_000023.11:g.18604169AG[1]
  • NG_008475.1:g.183565AG[1]
  • NM_001037343.2:c.1247_1248del
  • NM_001323289.2:c.1247_1248delMANE SELECT
  • NM_003159.3:c.1247_1248del
  • NP_001032420.1:p.Glu416fs
  • NP_001310218.1:p.Glu416fs
  • NP_003150.1:p.Glu416fs
  • NC_000023.10:g.18622289AG[1]
  • NC_000023.10:g.18622289_18622290del
  • NC_000023.11:g.18604171_18604172delAG
  • NM_003159.2(CDKL5):c.1247_1248delAG
  • NM_003159.2:c.1247_1248delAG
  • p.Glu416Valfs
Protein change:
E416fs
Links:
dbSNP: rs786204967
NCBI 1000 Genomes Browser:
rs786204967
Molecular consequence:
  • NM_001037343.2:c.1247_1248del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001323289.2:c.1247_1248del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_003159.3:c.1247_1248del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
CDKL5 disorder
Identifiers:
MONDO: MONDO:0100039; MedGen: CN296942

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001712024ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel
reviewed by expert panel

(ClinGen RettAS ACMG Specifications V1)
Pathogenic
(Mar 26, 2021)
germlinecuration

Citation Link,

SCV005335209Centre for Population Genomics, CPG
criteria provided, single submitter

(McKnight et al. (Hum Mutat. 2022))
Pathogenic
(Sep 18, 2024)
germlinecuration

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedcuration

Citations

PubMed

Recommendations by the ClinGen Rett/Angelman-like expert panel for gene-specific variant interpretation methods.

McKnight D, Bean L, Karbassi I, Beattie K, Bienvenu T, Bonin H, Fang P, Chrisodoulou J, Friez M, Helgeson M, Krishnaraj R, Meng L, Mighion L, Neul J, Percy A, Ramsden S, Zoghbi H, Das S.

Hum Mutat. 2022 Aug;43(8):1097-1113. doi: 10.1002/humu.24302. Epub 2021 Dec 2.

PubMed [citation]
PMID:
34837432
PMCID:
PMC9135956

Details of each submission

From ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel, SCV001712024.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The p.Glu416Valfs variant in CDKL5 is predicted to cause a premature stop codon that leads to a truncated or absent protein in a gene in which loss-of-function is an established mechanism. There is significant evidence that loss of this region of the gene is pathogenic (PVS1). The p.Glu416Valfs variant has been observed in at least 5 individuals with CDKL5 disease (PMID: 27779742, 27864847, 23064044, ClinVar Variation ID 189554) (PS4). The p.XX variant in GENE has been reported in at least 2 de novo occurrences (biological parentage unconfirmed) in individuals with CDKL5 disorder (PMID XX) (PMID 27779742, 27864847) (PM6_strong). This variant is absent from gnomAD (PM2_supporting). In summary, this variant meets criteria to be classified as pathogenic for CDKL5-associated disorder based on the ACMG/AMP criteria applied (PVS1, PS4, PM6_strong, PM2_supporting).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Centre for Population Genomics, CPG, SCV005335209.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (1)

Description

This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as pathogenic. At least the following criteria are met: Predicted to result in loss of function, and LOF is a known mechanism of disease (PVS1). Has been observed in at least 5 individuals with phenotypes consistent with CDKL5 disorder (PS4). PMID: 22872100, PMID: 23064044,PMID: 27779742, PMID: 30945278, PMID: 31164858, Variation ID: 189554 This variant is absent from gnomAD v4 (PM2_Supporting).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024